StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultAug 6, 2026, 05:19 PM

Nature's Sunshine Q2 Net Sales Up 2% to $117M; Net Income Down 34%

AI Summary

Nature's Sunshine Products Inc. reported mixed financial results for the second quarter and first half of 2026. While net sales increased by 2% to $117.0 million for the quarter and 5% to $239.9 million for the six months, net income attributable to common shareholders saw a significant decline, falling 34% to $3.5 million for the quarter and 14% to $8.7 million for the six months. The company's diluted EPS also decreased to $0.19 for the quarter and $0.48 for the six months. Additionally, shareholders approved a new 2026 Stock Incentive Plan, and the company continued its share repurchase program.

Key Highlights

  • Q2 2026 net sales increased 2% to $117.0 million from $114.8 million in Q2 2025.
  • Q2 2026 net income attributable to common shareholders decreased 34% to $3.5 million.
  • Diluted EPS for Q2 2026 was $0.19, down from $0.28 in Q2 2025.
  • H1 2026 net sales rose 5% to $239.9 million from $228.0 million in H1 2025.
  • H1 2026 net income attributable to common shareholders decreased 14% to $8.7 million.
  • Shareholders approved the 2026 Stock Incentive Plan on May 6, 2026, reserving 1.5 million shares.
  • The company repurchased 113,000 shares for $2.6 million during the first six months of 2026.
  • Asia segment net sales for Q2 2026 were $53.0 million, the largest regional contributor.